Valuation: Becton, Dickinson and Company

Capitalization 50.51B 42.74B 38.99B 37.28B 69.06B 4,581B 71.46B 454B 180B 2,210B 189B 186B 7,797B P/E ratio 2026 *
34x
P/E ratio 2027 * 27.5x
Enterprise value 68.66B 58.11B 53.01B 50.68B 93.88B 6,228B 97.14B 618B 245B 3,005B 258B 252B 10,599B EV / Sales 2026 *
3.56x
EV / Sales 2027 * 3.49x
Free-Float
77.04%
Yield 2026 *
2.15%
Yield 2027 * 2.2%
1 day+2.99%
1 week+6.41%
Current month-10.22%
1 month-11.80%
3 months-4.35%
6 months-6.77%
Current year-5.87%
1 week 175.51
Extreme 175.51
182.88
1 month 164.41
Extreme 164.41
213.08
Current year 164.41
Extreme 164.41
213.08
1 year 162.29
Extreme 162.29
235.34
3 years 162.29
Extreme 162.29
287.32
5 years 162.29
Extreme 162.29
287.32
10 years 142.38
Extreme 142.38
287.32
Manager TitleAgeSince
Chief Executive Officer 53 27/01/2020
Chief Tech/Sci/R&D Officer 50 31/12/2018
Compliance Officer - 31/01/2023
Director TitleAgeSince
Director/Board Member 75 23/09/2002
Director/Board Member 71 25/07/2010
Chairman 53 27/04/2021
Change 5d. change 1-year change 3-years change Capi.($)
+2.99%+6.41%-18.74%-25.29% 50.51B
+0.92%+0.90%-13.26%+6.14% 195B
+2.16%-2.89%+6.12%+16.14% 124B
+0.07%+0.06%+48.47%+123.07% 70.03B
+0.70%-4.04%+43.43%+103.65% 60.35B
+3.36%+5.34% - - 38.41B
+3.37%+6.81%-18.27%-36.56% 27.11B
+1.61%+1.91%+13.68%+31.47% 24.07B
+2.61%-1.90%-16.06%-47.04% 19.64B
+1.13%+7.49%-2.26%-22.01% 19.26B
Average +1.89%+0.19%+4.79%+16.62% 62.82B
Weighted average by Cap. +1.56%-0.64%+4.60%+25.79%

Financials

2026 *2027 *
Net sales 19.26B 16.3B 14.87B 14.22B 26.33B 1,747B 27.25B 173B 68.65B 843B 72.23B 70.74B 2,973B 19.72B 16.69B 15.22B 14.55B 26.96B 1,788B 27.89B 177B 70.28B 863B 73.94B 72.42B 3,044B
Net income 1.71B 1.45B 1.32B 1.26B 2.33B 155B 2.42B 15.37B 6.09B 74.73B 6.4B 6.27B 264B 2.07B 1.76B 1.6B 1.53B 2.84B 188B 2.93B 18.66B 7.39B 90.75B 7.78B 7.62B 320B
Net Debt 18.15B 15.36B 14.01B 13.4B 24.82B 1,646B 25.68B 163B 64.71B 794B 68.08B 66.67B 2,802B 18.31B 15.49B 14.13B 13.51B 25.03B 1,661B 25.9B 165B 65.26B 801B 68.66B 67.24B 2,826B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Calendar
03-09 -
Date Price Change Volume
18/02/26 182.68 $ +2.99% 2,693,158
17/02/26 177.38 $ +0.85% 2,237,887
13/02/26 175.89 $ -1.08% 3,167,457
12/02/26 177.81 $ -1.56% 8,302,802
11/02/26 180.62 $ +5.21% 5,939,008
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
177.38USD
Average target price
195.38USD
Spread / Average Target
+10.15%

Quarterly revenue - Rate of surprise